AR and prostate carcinoma: Although the PPIase activity is not necessary for enhancing AR activity, the FK1 catalytic pocket appears to be essential in potentiating the AR response to androgens via [105], such that treatments with FK506 reduce AR binding capacity and prevents the androgen-induced proliferation of prostate cancer cells.